PL2114878T3 - Związki 5-(heterocyklilo)alkilo-N-(arylosulfonylo)indolowe i ich zastosowanie jako ligandy 5-HT6 - Google Patents
Związki 5-(heterocyklilo)alkilo-N-(arylosulfonylo)indolowe i ich zastosowanie jako ligandy 5-HT6Info
- Publication number
- PL2114878T3 PL2114878T3 PL07827525T PL07827525T PL2114878T3 PL 2114878 T3 PL2114878 T3 PL 2114878T3 PL 07827525 T PL07827525 T PL 07827525T PL 07827525 T PL07827525 T PL 07827525T PL 2114878 T3 PL2114878 T3 PL 2114878T3
- Authority
- PL
- Poland
- Prior art keywords
- disorders
- compounds
- pharmaceutically acceptable
- arylsulfonyl
- heterocyclyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/08—Indoles; Hydrogenated indoles with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, directly attached to carbon atoms of the hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
- A61K31/404—Indoles, e.g. pindolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/34—Tobacco-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/36—Oxygen atoms in position 3, e.g. adrenochrome
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Psychiatry (AREA)
- Addiction (AREA)
- Diabetes (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Hospice & Palliative Care (AREA)
- Psychology (AREA)
- Pain & Pain Management (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IN45CH2007 | 2007-01-08 | ||
PCT/IN2007/000312 WO2008084492A1 (en) | 2007-01-08 | 2007-07-26 | 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands |
EP07827525A EP2114878B1 (en) | 2007-01-08 | 2007-07-26 | 5-(heterocyclyl)alkyl-n-(arylsulfonyl)indole compounds and their use as 5-ht6 ligands |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2114878T3 true PL2114878T3 (pl) | 2011-05-31 |
Family
ID=39495814
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL07827525T PL2114878T3 (pl) | 2007-01-08 | 2007-07-26 | Związki 5-(heterocyklilo)alkilo-N-(arylosulfonylo)indolowe i ich zastosowanie jako ligandy 5-HT6 |
Country Status (23)
Country | Link |
---|---|
US (1) | US8470830B2 (pl) |
EP (1) | EP2114878B1 (pl) |
JP (1) | JP2010515674A (pl) |
KR (1) | KR101103023B1 (pl) |
CN (1) | CN101553467B (pl) |
AT (1) | ATE491685T1 (pl) |
AU (1) | AU2007343063B2 (pl) |
BR (1) | BRPI0718737A2 (pl) |
CA (1) | CA2670717C (pl) |
CY (1) | CY1111105T1 (pl) |
DE (1) | DE602007011323D1 (pl) |
DK (1) | DK2114878T3 (pl) |
EA (1) | EA017007B1 (pl) |
ES (1) | ES2357584T3 (pl) |
HK (1) | HK1132273A1 (pl) |
IL (1) | IL198821A (pl) |
MX (1) | MX2009006077A (pl) |
NO (1) | NO341713B1 (pl) |
NZ (1) | NZ577769A (pl) |
PL (1) | PL2114878T3 (pl) |
PT (1) | PT2114878E (pl) |
WO (1) | WO2008084492A1 (pl) |
ZA (1) | ZA200903600B (pl) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8318725B2 (en) | 2008-09-17 | 2012-11-27 | Suven Life Sciences Limited | Aryl indolyl sulfonamide compounds and their use as 5-HT6 ligands |
CN103304547A (zh) * | 2012-03-13 | 2013-09-18 | 中国药科大学 | 一种抗抑郁药维拉唑酮的制备方法 |
EP3074378A4 (en) * | 2013-11-25 | 2017-05-10 | Novogen Ltd. | Functionalised and substituted indoles as anti-cancer agents |
EP3083588B1 (en) | 2013-12-20 | 2020-12-09 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic compounds and their application in pharmaceuticals |
WO2016004882A1 (en) | 2014-07-08 | 2016-01-14 | Sunshine Lake Pharma Co., Ltd. | Aromatic heterocyclic derivatives and pharmaceutical applications thereof |
MX2017000613A (es) * | 2014-07-16 | 2017-04-27 | Novogen ltd | Indoles funcionalizados y sustituidos como agentes anticancer. |
AU2021305165A1 (en) * | 2020-07-06 | 2023-02-02 | Tactogen Inc | Advantageous benzothiophene compositions for mental disorders or enhancement |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9026389D0 (en) * | 1990-12-05 | 1991-01-23 | Merck Sharp & Dohme | Therapeutic agents |
US5700823A (en) * | 1994-01-07 | 1997-12-23 | Sugen, Inc. | Treatment of platelet derived growth factor related disorders such as cancers |
DZ2376A1 (fr) | 1996-12-19 | 2002-12-28 | Smithkline Beecham Plc | Dérivés de sulfonamides nouveaux procédé pour leurpréparation et compositions pharmaceutiques les c ontenant. |
PL338016A1 (en) | 1997-07-11 | 2000-09-25 | Smithkline Beecham Plc | Novel chemical compounds |
GB9801392D0 (en) | 1998-01-22 | 1998-03-18 | Smithkline Beecham Plc | Novel compounds |
GB9803411D0 (en) | 1998-02-18 | 1998-04-15 | Smithkline Beecham Plc | Novel compounds |
CA2370147C (en) | 1999-04-21 | 2009-07-28 | Allelix Biopharmaceuticals Inc. | Piperidine-indole compounds having 5-ht6 affinity |
GB9926302D0 (en) | 1999-11-05 | 2000-01-12 | Smithkline Beecham Plc | Novel compounds |
BR0115102B1 (pt) * | 2000-11-02 | 2013-11-26 | Compostos 1-aril- ou 1-alquilsulfonil-heterociclilbenzazóis e composição compreendendo os mesmos | |
ES2272667T3 (es) | 2001-01-30 | 2007-05-01 | Eli Lilly And Company | Indol-5-il esteres del acido bencenosulfonico como antagonistas de receptor 5-ht6. |
BR0207302A (pt) | 2001-02-08 | 2004-02-10 | Memory Pharm Corp | Trifluorometilpurinas como inibidores da fosfodiesterase 4 |
CA2449874C (en) | 2001-06-07 | 2009-06-23 | F. Hoffmann-La Roche Ag | New indole derivatives with 5-ht6 receptor affinity |
US20040242589A1 (en) * | 2001-08-07 | 2004-12-02 | Bromidge Steven Mark | 3-arylsulfonyl-7-piperzinyl-indoles-benzofurans and -benzothiophenes with 5-ht6 receptor affinity for treating cns disorders |
WO2003065046A2 (en) | 2002-02-01 | 2003-08-07 | Bayer Healthcare Ag | Diagnostics and therapeutics for diseases associated with a new human 5-ht6 receptor |
US20070270432A1 (en) | 2002-02-05 | 2007-11-22 | James Hagan | Novel Method |
EP1956004B1 (en) | 2002-03-27 | 2012-06-13 | Glaxo Group Limited | Quinoline derivatives and their use as 5-HT6 ligands |
JP4559230B2 (ja) * | 2002-11-28 | 2010-10-06 | スベン ライフ サイエンシズ リミティド | セロトニン受容体に対する親和性を有する新規n−アリールスルホニル−3−置換されたインドール、その調製方法、それを含有する医薬組成物 |
WO2004048328A2 (en) | 2002-11-28 | 2004-06-10 | Suven Life Sciences Limited | N-arylsulfonyl-3-aminoalkoxyindoles |
AU2003292508A1 (en) | 2002-11-28 | 2004-06-18 | Suven Life Sciences Limited | N-arylalkyl-3-aminoalkoxyindoles and their use as 5-ht ligands |
ATE355292T1 (de) | 2002-12-18 | 2006-03-15 | Suven Life Sciences Ltd | Tetrazyklische 3-substituierte indole mit serotoninrezeptoraffinität |
WO2004108671A1 (en) * | 2003-06-06 | 2004-12-16 | Suven Life Sciences Limited | Substituted indoles with serotonin receptor affinity, process for their preparation and pharmaceutical compositions containing them |
ES2222828B1 (es) * | 2003-07-30 | 2006-04-16 | Laboratorios Del Dr. Esteve, S.A. | Derivados de 1-sulfonilindoles, su preparacion y su aplicacion como medicamentos. |
SI1919896T1 (sl) | 2005-08-12 | 2010-04-30 | Suven Life Sciences Ltd | Aminoaril sulfonamidni derivati kot funkcionalni 5-HT6 ligandi |
BRPI0712898A2 (pt) * | 2006-07-03 | 2013-01-08 | Biovitrum Ab | indàis como moduladores de 5-ht6 |
-
2007
- 2007-07-26 DE DE602007011323T patent/DE602007011323D1/de active Active
- 2007-07-26 MX MX2009006077A patent/MX2009006077A/es active IP Right Grant
- 2007-07-26 ES ES07827525T patent/ES2357584T3/es active Active
- 2007-07-26 AU AU2007343063A patent/AU2007343063B2/en not_active Ceased
- 2007-07-26 NZ NZ577769A patent/NZ577769A/en not_active IP Right Cessation
- 2007-07-26 PT PT07827525T patent/PT2114878E/pt unknown
- 2007-07-26 PL PL07827525T patent/PL2114878T3/pl unknown
- 2007-07-26 BR BRPI0718737-8A2A patent/BRPI0718737A2/pt not_active Application Discontinuation
- 2007-07-26 EP EP07827525A patent/EP2114878B1/en active Active
- 2007-07-26 DK DK07827525.2T patent/DK2114878T3/da active
- 2007-07-26 JP JP2009544495A patent/JP2010515674A/ja active Pending
- 2007-07-26 EA EA200970675A patent/EA017007B1/ru not_active IP Right Cessation
- 2007-07-26 CA CA2670717A patent/CA2670717C/en not_active Expired - Fee Related
- 2007-07-26 AT AT07827525T patent/ATE491685T1/de active
- 2007-07-26 KR KR1020097011686A patent/KR101103023B1/ko not_active Expired - Fee Related
- 2007-07-26 US US12/521,967 patent/US8470830B2/en not_active Expired - Fee Related
- 2007-07-26 WO PCT/IN2007/000312 patent/WO2008084492A1/en active Application Filing
- 2007-07-26 CN CN2007800454515A patent/CN101553467B/zh not_active Expired - Fee Related
-
2009
- 2009-05-19 IL IL198821A patent/IL198821A/en active IP Right Grant
- 2009-05-25 ZA ZA200903600A patent/ZA200903600B/xx unknown
- 2009-05-27 NO NO20092067A patent/NO341713B1/no not_active IP Right Cessation
- 2009-12-29 HK HK09112256.5A patent/HK1132273A1/xx not_active IP Right Cessation
-
2011
- 2011-01-13 CY CY20111100042T patent/CY1111105T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
CY1111105T1 (el) | 2015-06-11 |
US20100041673A1 (en) | 2010-02-18 |
BRPI0718737A2 (pt) | 2014-03-25 |
EA017007B1 (ru) | 2012-09-28 |
CN101553467A (zh) | 2009-10-07 |
AU2007343063A1 (en) | 2008-07-17 |
CA2670717C (en) | 2012-01-10 |
ES2357584T3 (es) | 2011-04-27 |
KR101103023B1 (ko) | 2012-01-05 |
NO20092067L (no) | 2009-09-04 |
HK1132273A1 (pl) | 2010-02-19 |
NZ577769A (en) | 2011-01-28 |
US8470830B2 (en) | 2013-06-25 |
EA200970675A1 (ru) | 2009-12-30 |
ZA200903600B (en) | 2010-07-28 |
AU2007343063A8 (en) | 2009-07-23 |
IL198821A0 (en) | 2010-02-17 |
EP2114878A1 (en) | 2009-11-11 |
KR20090080544A (ko) | 2009-07-24 |
IL198821A (en) | 2014-11-30 |
ATE491685T1 (de) | 2011-01-15 |
WO2008084492A1 (en) | 2008-07-17 |
CN101553467B (zh) | 2011-12-07 |
NO341713B1 (no) | 2018-01-08 |
AU2007343063B2 (en) | 2011-02-17 |
PT2114878E (pt) | 2011-03-10 |
CA2670717A1 (en) | 2008-07-17 |
EP2114878B1 (en) | 2010-12-15 |
DE602007011323D1 (de) | 2011-01-27 |
MX2009006077A (es) | 2009-06-17 |
JP2010515674A (ja) | 2010-05-13 |
DK2114878T3 (da) | 2011-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA200903600B (en) | 5-(Heterocyclyl)alkyl-N-(arylsulfonyl)indole compounds and their use as 5-HT6 ligands | |
MY167135A (en) | Fused heterocyclic derivatives and methods of use | |
MX2010007683A (es) | Derivados heterociclicos fusionados y metodos de uso como inhibidores de c-met. | |
MX2009000900A (es) | Derivados de imidazolonas sustituidas, preparacion y usos. | |
MX2014000964A (es) | Derivados aza heterociclicos sustituidos. | |
MY147890A (en) | 9-(pyrazol-3-yl)-9h-purine-2-amine and 3-(pyraz0l-3-yl)-3h-imidaz0 [4,5-b] pyridin-5-amine derivatives and their use for the treatment of cancer | |
UA104988C2 (uk) | Похідні піроніндолу та спосіб їх отримання | |
MY147677A (en) | Piperazinyl derivatives useful in the treatment of gpr38 receptor mediated diseases | |
HK1138264A1 (en) | Aminoalkoxy aryl sulfonamide compounds and their use as 5-ht6 ligands | |
MX2009006757A (es) | Compuestos de 4-(heterociclil)alquil-n-(arilsulfonil) indol y su uso como ligandos de la 5-hidroxitriptamina6. | |
MX2007006387A (es) | Derivados de piridina 3-substituidos como antagonistas h3. | |
HRP20110780T1 (en) | Amino arylsulfonamide compounds and their use as 5-ht6 ligands field of invention | |
MX2013001988A (es) | Compuestos de heterociclilo comoligandos del receptor h3 de la histamina | |
PL1732902T3 (pl) | Pochodne nukleozydów i ich terapeutyczne zastosowanie |